Kyoto University Innovation Capital Co., Ltd. ("Kyoto iCAP") (Headquarters: Sakyo-ku, Kyoto; Representative Director: Ko Kusumi) would like to announce that it has established the Innovation Kyoto 2026 Investment Limited Partnership (KYOTO-iCAP Fund Ⅲ), for which Kyoto iCAP serves as the general partner.

To date, Kyoto iCAP has supported startups aiming to commercialize research outcomes from Kyoto University and other Japanese national universities through the Innovation Kyoto 2016 Investment Limited Partnership (KYOTO-iCAP Fund I) which was established in 2016, and the Innovation Kyoto 2021 Investment Limited Partnership (KYOTO-iCAP Fund Ⅱ) which was established in 2021.

As with the KYOTO-iCAP Fund Ⅰ and KYOTO-iCAP Fund Ⅱ, the KYOTO-iCAP Fund Ⅲ will invest in startups originating from Kyoto University and other Japanese national universities from the early stages of their development. By supporting portfolio companies in advancing their business stages, the Fund aims to accelerate further growth by attracting private capital and to achieve strong investment returns. The KYOTO-iCAP Fund Ⅲ has a fund life of 15 years, with the possibility of a two-year extension subject to the consent of the limited partners. Compared with typical venture capital funds, the Fund’s significantly longer duration enables patient capital investment and sustained support for the development of startup businesses.

As of now, the following organizations are participating as limited partners in the KYOTO-iCAP Fund Ⅲ: Astellas Pharma Inc.; The Senshu Ikeda Bank, Ltd.; Bank of Kyoto, Ltd. and Kyoto Capital Partners Co., Ltd.; Kyoto Chuo Shinkin Bank; Cosmo Energy Holdings Co., Ltd.; Shimadzu Corporation; Tokyu Land Corporation; Nippon Life Insurance Company; and Sumitomo Mitsui Trust Bank, Limited. Additional limited partners are expected to join in the future, and the Fund ultimately aims to reach a total committed capital of up to JPY 20 billion.

Overview of the KYOTO-iCAP Fund Ⅲ
Name : Innovation Kyoto 2026 Investment Limited Partnership
Legal Basis : Act on Strengthening Industrial Competitiveness and Limited Partnership Act for Investment
General Partner : Kyoto University Innovation Capital Co., Ltd.
Limited Partners : Astellas Pharma Inc.; The Senshu Ikeda Bank, Ltd.; Bank of Kyoto, Ltd. and Kyoto Capital Partners Co., Ltd.; Kyoto Chuo Shinkin Bank; Cosmo Energy Holdings Co., Ltd.; Shimadzu Corporation; Tokyu Land Corporation; Nippon Life Insurance Company; Sumitomo Mitsui Trust Bank, Limited (in Japanese alphabetical order)
Target Fund Size: Up to JPY 20 billion
Fund Term : 15 years (with a possible two-year extension)

Contact information for inquiries
Kyoto University Innovation Capital, Co. Ltd.
36-1 Yoshida Honmachi, Sakyo-ku, Kyoto 606-8317, Japan
Osami Kono, Senior Officer, Business Development Department
TEL: 075-753-7588 FAX: 075-753-7592
E-mail：info@kyoto-unicap.co.jp